Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Conmed Q2 Adj. EPS $1.15 Beats $1.12 Estimate, Sales $342.345M Beat $338.167M Estimate

Author: Benzinga Newsdesk | July 30, 2025 03:06pm
Conmed (NYSE:CNMD) reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $1.12 by 2.4 percent. This is a 17.35 percent increase over earnings of $0.98 per share from the same period last year. The company reported quarterly sales of $342.345 million which beat the analyst consensus estimate of $338.167 million by 1.24 percent. This is a 3.09 percent increase over sales of $332.097 million the same period last year.

Posted In: CNMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist